Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Novo och Astra ligger bra till i internationell kraftmätning

Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

How to get the most out of the fair

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...

”Alla skriker efter talang”

Att locka till sig begåvningarna är en av life science-branschens stora framtidsutmaningar. Det var en av slutsatserna i det panelsamtal som avslutade konferensen New Horizons in Biologics & Bioprocessing på torsdagen....

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

Konferens om läkemedelsformuleringar samlar branschen i Köpenhamn

Idag pågår den tionde upplagan av New Updates in Drug Formulation & Bioavailability 2022 i Köpenhamn.

Genterapier och vaccin dryftas på branschmötet

Stort intresse för New Horizons

Just nu pågår livesändningen av Life Science Swedens event New Horizons in Biologics & Bioprocessing – och intresset är rekordstort.

Hallå där Johan Rockberg...

Johan Rockberg, forskare vid KTH, ska moderera Life Science Swedens event New Horizons in Biologics & Bioprocessing den 17 december.

Hallå där Korbinian Löbmann

Korbinian Löbmann kommer att moderera Life Science Swedens kommande event New updates in Drug Formulation & Bioavailability den 1 september.

”Viktigt att bolla idéer också under pandemin”

Ragna Berthelsen modererade den första upplagan av New Updates in Drug Formulation & Bioavailability som digitalt event.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Nya datum för spännande event

The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability flyttas fram till september.